Human Papillomavirus (HPV) E6/E7 mRNA Genotyping Detection Kit

A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.

In vitro qualitative detection kit for 15 high-risk HPV E6/E7 mRNA subtypes in cervical exfoliated cell samples. Detects HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 for cervical cancer and precancerous lesion risk assessment. NMPA Class III medical device registered.

Multiplex real-time PCR kit for simultaneous detection and genotyping of human papillomavirus (HPV) E6/E7 mRNA targets. Enables identification of multiple HPV genotypes in a single reaction, supporting cervical cancer screening and risk stratification in clinical laboratories.

Real-time PCR kit for detection and genotyping of HPV E6/E7 mRNA in clinical specimens. Enables rapid identification of high-risk HPV types through multiplex amplification technology, supporting cervical cancer screening and risk stratification in molecular diagnostics laboratories.

HPV E7 protein detection system for cervical cytology screening. Identifies HPV E7 biomarkers in cervical samples for disease risk assessment. Supports early detection of HPV-related cervical pathology.

HPV E7 protein detection kit using immunocytochemical methodology for cervical cytology screening. This in vitro diagnostic test identifies HPV E7 protein expression in cervical samples to support the detection of cervical lesions and dysplasia. The kit enables standardized pathology assessment with compatible automated analysis integration for improved diagnostic accuracy.

Molecular diagnostic test for human papillomavirus detection using polymerase chain reaction technology. Enables nucleic acid-based identification of HPV pathogens for clinical screening applications.

This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.

Molecular diagnostic test for detection and genotyping of human papillomavirus. Supports cervical cancer screening and HPV-related disease diagnosis.

A nucleic acid-based PCR test kit for genotyping of human papillomavirus. Provides comprehensive identification of HPV strains for clinical assessment.

PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.

A fully enclosed diagnostic kit with preloaded reagents for 6-plex detection of HPV types (HPV16, HPV18, and others) using cervical exfoliated cells and genital secretion samples. The kit employs magnetic beads extraction, purification, and qPCR method with results available within 2 hours and internal control monitoring throughout the process. It requires no freezer storage or transportation.